TTRX insider transaction filings
Turn Therapeutics Inc. — 23 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-08. Screen TTRX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-08 | 4 | Dewhurst Martin William — Director | Grant/award (A): 71,666 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Kester Kent Edward — Director | Grant/award (A): 83,334 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Gengos Andrew — Director | Grant/award (A): 95,000 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | GOLDEN ARTHUR F — Director | Grant/award (A): 89,584 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | Burnam Bradley Evan — Chief Executive Officer, Director, 10% owner BEB Holdings, LLC — 10% owner | Gift (G): 300,000 @ $0 · Gift (G): 300,000 @ $0 · Gift (G): 300,000 @ $0 · Gift (G): 300,000 @ $0 | EDGAR |
| 2026-04-03 | 4 | Burnam Bradley Evan — Chief Executive Officer, Director, 10% owner BEB Holdings, LLC — 10% owner | Gift (G): 300,000 @ $0 | EDGAR |
| 2026-04-03 | 4 | Burnam Bradley Evan — Chief Executive Officer, Director, 10% owner BEB Holdings, LLC — 10% owner | Grant/award (A): 160,000 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Chaudhary Zuraiz — See Remarks | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | GOLDEN ARTHUR F — Director | Gift (G): 300,000 @ $0 | EDGAR |
| 2026-02-04 | 4 | Dewhurst Martin William — Director | Grant/award (A): 21,882 @ $0 | EDGAR |
| 2025-12-12 | 4 | Chaudhary Zuraiz — See Remarks | Purchase (P): 2,500 @ $3.50 | EDGAR |
| 2025-11-25 | 4 | GOLDEN ARTHUR F — Director | Purchase (P): 9,868 @ $3.44 | EDGAR |
| 2025-11-24 | 4 | GOLDEN ARTHUR F — Director | Purchase (P): 20,532 @ $2.87 | EDGAR |
| 2025-11-21 | 4 | Chaudhary Zuraiz — See Remarks | Purchase (P): 1,450 @ $2.61 · Purchase (P): 1,000 @ $3.29 | EDGAR |
| 2025-11-17 | 4 | Chaudhary Zuraiz — See Remarks | Purchase (P): 2,500 @ $3.62 | EDGAR |
| 2025-10-29 | 4 | Chesed Abraham | Purchase (P): 14,286 @ $4.60 | EDGAR |
| 2025-10-23 | 4 | Chaudhary Zuraiz — See Remarks | Purchase (P): 5,050 @ $4.95 | EDGAR |
| 2025-10-23 | 4 | GOLDEN ARTHUR F — Director | Purchase (P): 20,202 @ $4.95 | EDGAR |
| 2025-10-10 | 4 | Ghodadra Neilesh Shailesh — Chief Medical Officer, Director | Grant/award (A): 10,000 @ $0 | EDGAR |
| 2025-10-10 | 4 | Kester Kent Edward — Director | Grant/award (A): 10,000 @ $0 | EDGAR |
| 2025-10-10 | 4 | Chaudhary Zuraiz — See Remarks | Grant/award (A): 240,000 (derivative) @ $0 | EDGAR |
| 2025-10-10 | 4 | Gengos Andrew — Director | Grant/award (A): 10,000 @ $0 | EDGAR |
| 2025-10-10 | 4 | GOLDEN ARTHUR F — Director | Grant/award (A): 10,000 @ $0 | EDGAR |
Recent 8-K events — Turn Therapeutics Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-18 | 8-K | 3.02 — Unregistered Sales of Equity Securities | EDGAR |
| 2026-08-17 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-28 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-07 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-03 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-01 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-27 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-19 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-18 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=TTRX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →